Last reviewed · How we verify

Tazarotene Lotion, 0.1%

Dr. Reddy's Laboratories Limited · Phase 2 active Small molecule

Tazarotene Lotion, 0.1% is a Small molecule drug developed by Dr. Reddy's Laboratories Limited. It is currently in Phase 2 development. Also known as: DFD-03 Lotion.

At a glance

Generic nameTazarotene Lotion, 0.1%
Also known asDFD-03 Lotion
SponsorDr. Reddy's Laboratories Limited
ModalitySmall molecule
PhasePhase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Tazarotene Lotion, 0.1%

What is Tazarotene Lotion, 0.1%?

Tazarotene Lotion, 0.1% is a Small molecule drug developed by Dr. Reddy's Laboratories Limited.

Who makes Tazarotene Lotion, 0.1%?

Tazarotene Lotion, 0.1% is developed by Dr. Reddy's Laboratories Limited (see full Dr. Reddy's Laboratories Limited pipeline at /company/dr-reddy-s-laboratories-limited).

Is Tazarotene Lotion, 0.1% also known as anything else?

Tazarotene Lotion, 0.1% is also known as DFD-03 Lotion.

What development phase is Tazarotene Lotion, 0.1% in?

Tazarotene Lotion, 0.1% is in Phase 2.

Related